Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Datadog, Inc.DDOG · Entity 2027 | Chief Product Officer | September 11, 2026 | September 15, 2026 |
| EQUINIX INCEQIX · Entity 2047 | Director | May 21, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Datadog, Inc.
Report date September 11, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 250,446 |
Ending reported balance
After 2026-09-11 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-09-11 · Sale · Disposed 400 · Balance 262,746 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $218.70 to $219.38. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 2 · 2026-09-11 · Sale · Disposed 3,700 · Balance 259,046 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F3: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $219.88 to $220.87. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2026-09-11 · Sale · Disposed 7,300 · Balance 251,746 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F4: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $220.88 to $221.75. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 4 · 2026-09-11 · Sale · Disposed 700 · Balance 251,046 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F5: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $221.90 to $222.45. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Row 5 · 2026-09-11 · Sale · Disposed 300 · Balance 250,746 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. Row 6 · 2026-09-11 · Sale · Disposed 300 · Balance 250,446 F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F6: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $224.83 to $224.91. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026.
F2: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $218.70 to $219.38. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $219.88 to $220.87. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F4: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $220.88 to $221.75. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F5: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $221.90 to $222.45. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F6: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $224.83 to $224.91. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
EQUINIX INC
Report date May 21, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 255 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 255 · Balance 255 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-21 · Exercise / conversion · Disposed 255 · Balance 0 F1: The Restricted Stock Units shall vest on the earlier of (i) May 21, 2026 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2: Restricted stock unit award expires upon reporting person's termination of service. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Stock Units shall vest on the earlier of (i) May 21, 2026 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date.
F2: Restricted stock unit award expires upon reporting person's termination of service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEOPHOTONICS CORP
Report date August 03, 2022 · Filed August 05, 2022
Section 16 reporting ended · disclosed 2022-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 1
1 source rowRow 1 · 2022-08-03 · Disposition to issuer · Disposed 13,207 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.17 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-08-03 · Disposition to issuer · Disposed 3,821 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Restricted Stock Unit (right to acquire)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-08-03 · Disposition to issuer · Disposed 5,787 · Balance 0 F3: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option.
F3: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 300 | $224.88 | $67,463.01 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 6 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,446 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F6 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $224.83 to $224.91. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 300 | $223.03 | $66,909.00 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 5 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,746 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 700 | $222.18 | $155,523.97 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 4 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,046 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F5 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $221.90 to $222.45. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 7,300 | $221.42 | $1,616,372.57 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 3 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,746 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F4 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $220.88 to $221.75. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 3,700 | $220.57 | $816,104.19 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 2 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 259,046 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F3 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $219.88 to $220.87. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 20:38 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 400 | $219.05 | $87,618.00 |
DisclosureSEC source: 0001561550-26-000309 · wk-form4_1789504696.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 262,746 F1 · kind: Shares sold pursuant to a 10b5-1 plan dated June 12, 2026. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $218.70 to $219.38. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 20:37 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 11,206 | $212.90 | $2,385,805.59 |
DisclosureSEC source: 0001561550-26-000294 · wk-form4_1788554226.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 263,146 F1 · kind: The Reporting Person was required by the Issuer to sell only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units and performance-based restricted stock units, as well as any related brokerage commission fees. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $210.12 to $213.01. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 21:43 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 11,070 | $267.15 | $2,957,399.21 |
DisclosureSEC source: 0001561550-26-000180 · wk-form4_1780609436.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,352 F1 · kind: The Reporting Person was required by the Issuer to sell only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units and performance-based restricted stock units, as well as any related brokerage commission fees. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $267.15 to $268.44. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 139 shares acquired on May 15, 2026 under the Issuers Employee Stock Purchase Plan. Read SEC document |
| May 21, 2026 Filed May 21, 2026 23:06 UTC | EQUINIX INC EQIX · Entity 2047 | Exercise / conversionRestricted Stock Units · Derivative | 255 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001101239-26-000115 · form4.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 255 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 21, 2026 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| May 21, 2026 Filed May 21, 2026 23:06 UTC | EQUINIX INC EQIX · Entity 2047 | Exercise / conversionCommon Stock | 255 | $0.00 | $0.00 |
DisclosureSEC source: 0001101239-26-000115 · form4.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:05 UTC | EQUINIX INC EQIX · Entity 2047 | GrantRestricted Stock Unit · Derivative | 241 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001101239-26-000108 · form4.xml · derivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241 Underlying: Common Stock · 241 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 13, 2027 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:15 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 19,834 | $197.35 | $3,914,281.55 |
DisclosureSEC source: 0001561550-26-000139 · wk-form4_1778616917.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,283 F1 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $197.32 to $197.55. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:55 UTC | Datadog, Inc. DDOG · Entity 2027 | GrantClass A Common Stock | 51,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001561550-26-000108 · wk-form4_1775249751.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 305,117 F1 · shares: Represents the number of shares of Class A Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Class A Common Stock. The shares underlying the RSUs vest as to 12/48 of the shares on March 1, 2027 and the remainder of the shares vest in 12 equal installments on each June 1, September 1, December 1 and March 1 thereafter, subject to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:09 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 23,023 | $110.54 | $2,544,865.72 |
DisclosureSEC source: 0001561550-26-000072 · wk-form4_1772658592.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,001 F1 · kind: The Reporting Person was required by the Issuer to sell only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units and performance-based restricted stock units, as well as any related brokerage commission fees. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $111.53 to $111.73. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 22:22 UTC | Datadog, Inc. DDOG · Entity 2027 | GrantClass A Common Stock | 77,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001561550-26-000027 · wk-form4_1770675725.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,024 F1 · shares: On April 1, 2025, the Reporting Person was granted restricted stock units, the vesting of which was subject to both performance-based and service-based criteria ("PSUs"). The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Such earned PSUs will vest as to service as to 1/4 of the shares on March 1, 2026 and 1/12 of the remaining shares on each June 1, September 1, December 1 and March 1 thereafter, subject in each case to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 22:34 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 6,715 | $158.60 | $1,064,988.93 |
DisclosureSEC source: 0001561550-25-000346 · wk-form4_1764887689.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,394 F1 · kind: The Reporting Person was required by the Issuer to sell only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units and performance-based restricted stock units, as well as any related brokerage commission fees. F2 · balance_after: Includes 74 shares acquired on November 14, 2025 under the Issuers Employee Stock Purchase Plan. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:46 UTC | Datadog, Inc. DDOG · Entity 2027 | SaleClass A Common Stock | 25,010 | $133.85 | $3,347,515.97 |
DisclosureSEC source: 0001561550-25-000254 · wk-form4_1757025999.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,035 F1 · kind: The Reporting Person was required by the Issuer to sell only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units and performance-based restricted stock units, as well as any related brokerage commission fees. F2 · price: Price reported is a weighted-average sales price. The shares were sold at prices ranging from $132.92 to $133.85. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 327 shares acquired on May 15, 2025 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 22:23 UTC | EQUINIX INC EQIX · Entity 2047 | GrantRestricted Stock Units · Derivative | 255 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-020484 · form4.xml · derivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255 Underlying: Common Stock · 255 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Stock Units shall vest on the earlier of (i) May 21, 2026 or (ii) if the reporting person does not stand for re-election as a director of the Company, the date of the regular meeting of the Company's stockholders held in the calendar year subsequent to the grant date; provided that, in either case, the reporting person remains in continuous Service through such vesting date. F2 · derivative.expiration_date: Restricted stock unit award expires upon reporting person's termination of service. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 20:20 UTC | Datadog, Inc. DDOG · Entity 2027 | GrantClass A Common Stock | 38,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001561550-25-000098 · wk-form4_1743711604.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,718 F1 · shares: Represents the number of shares of Class A Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Class A Common Stock. The shares underlying the RSUs vest as to 12/48 of the shares on March 1, 2026 and the remainder of the shares vest in 12 equal installments on each June 1, September 1, December 1 and March 1 thereafter, subject to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date. Read SEC document |
| February 25, 2025 Filed Feb 27, 2025 21:12 UTC | Datadog, Inc. DDOG · Entity 2027 | GrantClass A Common Stock | 102,776 | $0.00 | $0.00 |
DisclosureSEC source: 0001561550-25-000036 · wk-form4_1740690771.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,903 F1 · shares: On September 27, 2024, the Reporting Person was granted restricted stock units, the vesting of which was subject to both performance-based and service-based criteria ("PSUs"). The number of shares reported represents the number of PSUs that were earned as a result of the achievement of such performance criteria. Such earned PSUs will vest as to service as to 1/4 of the shares on March 1, 2025 and 1/12 of the remaining shares on each June 1, September 1, December 1 and March 1 thereafter, subject in each case to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date. Read SEC document |
| September 27, 2024 Filed Sep 27, 2024 20:15 UTC | Datadog, Inc. DDOG · Entity 2027 | GrantClass A Common Stock | 89,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001561550-24-000150 · wk-form4_1727468123.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,127 F1 · shares: Represents the number of shares of Class A Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Class A Common Stock. The shares underlying the RSUs vest as to 12/48 of the shares on September 1, 2025 and the remainder of the shares vest in 12 equal installments on each December 1, March 1, June 1, and September 1 thereafter, subject to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 23:14 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerRestricted Stock Unit (right to acquire) · Derivative | 5,787 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-22-044661 · doc4.xml · derivative · entry 3 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,787 shares Expires not disclosed F3 · price: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. F3 · derivative.exercise_date: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. F3 · derivative.expiration_date: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 23:14 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 3,821 | Not disclosed Strike: $10.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-044661 · doc4.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,821 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 23:14 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerCommon Stock | 13,207 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-044661 · doc4.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 22:11 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantRestricted Stock Units (right to acquire) · Derivative | 5,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000077 · edgardoc.xml · derivative · entry 3 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,787 Underlying: Common Stock · 5,787 shares Expires 2023-06-02 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:11 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionRestricted Stock Units (right to acquire) · Derivative | 4,621 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000077 · edgardoc.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,621 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:11 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 4,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000077 · edgardoc.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,820 | $0.00 Strike: $10.17 | $0.00 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · derivative · entry 10 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,821 Underlying: Common Stock · 3,820 shares Expires 2031-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,960 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · derivative · entry 9 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,960 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,665 | $0.00 Strike: $4.37 | $0.00 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · derivative · entry 8 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,665 shares Expires 2029-07-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | SaleCommon Stock | 7,397 | $15.33 | $113,381.22 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 7 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,586 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | SaleCommon Stock | 18,665 | $15.32 | $286,037.39 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 6 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,983 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 18,665 | $4.37 | $81,566.05 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 5 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | SaleCommon Stock | 8,960 | $15.32 | $137,310.21 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 4 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,983 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 8,960 | $8.56 | $76,697.60 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 3 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | SaleCommon Stock | 3,820 | $15.32 | $58,540.74 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,983 Read SEC document |
| December 09, 2021 Filed Dec 13, 2021 21:45 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 3,820 | $10.17 | $38,849.40 |
DisclosureSEC source: 0001227025-21-000254 · edgardoc.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 21:44 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionRestricted Stock Units (right to acquire) · Derivative | 5,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-21-000144 · edgardoc.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,228 shares Expires 2021-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 21:44 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 5,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001227025-21-000144 · edgardoc.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 22:26 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantRestricted Stock Units (right to acquire) · Derivative | 4,621 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-21-000126 · edgardoc.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,621 Underlying: Common Stock · 4,621 shares Expires 2022-06-01 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F3 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 22:26 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,641 | $0.00 Strike: $10.17 | $0.00 |
DisclosureSEC source: 0001227025-21-000126 · edgardoc.xml · derivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,641 Underlying: Common Stock · 7,641 shares Expires 2031-05-31 F1 · derivative.exercise_date: This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 04, 2020 Filed Jun 8, 2020 23:55 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantRestricted Stock Units (right to acquire) · Derivative | 5,228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-20-000114 · edgardoc.xml · derivative · entry 1 Li Yanbing · CIK 0001783061 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,228 Underlying: Common Stock · 5,228 shares Expires 2021-06-04 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 21:33 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 8,960 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001227025-20-000098 · edgardoc.xml · derivative · entry 1 Li Yanbing · CIK 0001783061 · Director · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,960 Underlying: Common Stock · 8,960 shares Expires 2030-06-01 F1 · derivative.exercise_date: This option shall vest ratably at a rate of 1/12th of the total number of shares granted on each monthly anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| July 03, 2019 Filed Jul 26, 2019 18:02 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,665 | $4.37 Strike: $4.37 | $81,566.05 |
DisclosureSEC source: 0001783061-19-000021 · edgardoc.xml · derivative · entry 2 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,665 Underlying: Common Stock · 18,665 shares Expires 2029-07-02 F2 · date: Shares shall vest at a rate of 1/12th of the total number of Option Shares on each monthly anniversary of the vesting commencement date, subject to the recipient's continued service through such date. Read SEC document |
| July 03, 2019 Filed Jul 26, 2019 18:02 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantCommon Stock | 10,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001783061-19-000021 · edgardoc.xml · nonDerivative · entry 1 Li Yanbing · CIK 0001783061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,755 F1 · date: 100% of the underlying shares shall vest on the one-year anniversary of the Vesting Commencement Date, subject to the recipient's continued service through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.